We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Agfa to Acquire Heartlab for $132 Million

By HospiMedica staff writers
Posted on 26 Apr 2005
Print article
Agfa (Mortsel, Belgium) has reached an agreement to acquire all of the shares of Heartlab, Inc. (Westerly, RI, USA), a designer and supplier of image and information networks for cardiology, for U.S.$132.5 million in cash.

This move is designed tostrengthen Agfa's position in healthcare information technology (IT), considerably enhancing its cardiology systems portfolio. Heartlab has contributed to the creation of industry standards and the development of clinical products that improve the management of cardiovascular disease.

Agfa and Heartlab have been working together since December 2003, within a distribution agreement for Agfa's Impax for Cardiology. This joint system allows for the smooth integration of radiology and cardiology, the two most image-intensive departments within hospitals, enabling data to flow more efficiently within the healthcare system and facilitating management of the electronic patient record. This system incorporates the clinical technology and diagnostic tools of both companies' integration and workflow expertise.

"The combination of Heartlab and Agfa will result in substantial growth based on an even more competitive solutions portfolio and our presence and reputation in leading hospitals around the world,” said Ludo Verhoeven, president and CEO of Agfa. "This is an important step in implementing our healthcare strategy and fits well with recent acquisitions.”

Heartlab CEO and co-founder Robert Petrocelli commented, "Joining Agfa offers Heartlab new opportunities in global markets, and thereby strengthens the portfolio and benefits our customers and their patients.” After the acquisition closes, Mr. Petrocelli will manage Agfa's Cardiology business unit.





Related Links:
Agfa
Heartlab
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
New
Hospital Bed Mattress Cover
Skin IQ 365
New
Pressure Monitoring Mattress
Entrix NX

Print article

Channels

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.